Guided <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Receives Third Payment and New Order from Chinese Distributor
Guided Therapeutics Inc. announced the receipt of an $88,000 payment from its distribution partner, Hangzhou Dongye Medical Technology Company Ltd (HDMT). Of this amount, $80,000 represents the third installment of a previously announced $700,000 purchase order, with the remaining $8,000 attributed to a new order for LuViva device components. Four LuViva devices and components are scheduled for shipment this month, bringing the total shipped to seven out of 35 devices expected over the coming months. HDMT is the exclusive gynecology products provider for 42 hospitals in Zhejiang Province, China. In addition, Guided Therapeutics recently entered into an agreement with Yuanshuo Medical Instruments Corporation (YMIC) for an initial $200,000 purchase of LuViva devices and parts, with YMIC set to distribute the products in Jiangsu province.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guided Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251211649678) on December 11, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.